ExaWizards and MDV Sign a MOU on Multimodal AI-Enabled Data-Driven Business 〜Utilising the country's largest medical big data held by MDV, Contributing to the development of new services for the field of rare diseases〜

NEWS

ExaWizards Inc. (Headquarters: Minato-ku, Tokyo; Representative Director & President: Makoto Haruta; hereafter, “ExaWizards”), announces that it signed a memorandum of understanding with Medical Data Vision Co., Ltd. (Headquarters: Chiyoda-ku, Tokyo; President: Hiroyuki Iwasaki; hereafter, “MDV”) to have a business collaboration agreement on a multimodal AI-enabled data-driven business. Under the agreement, ExaWizards’ multimodal AI technology*1 will be utilised in the country’s largest medical big data held by MDV, which includes 43.22 million hospital data and 19.11 million insurer data, to predict disease onset and recurrence, provide services in the field of rare diseases and develop patient-centred services. development, etc.
Digitization and integration of medical information is considered an important issue internationally, but in Japan, it is not progressing as well as expected. On the other hand, with the rapid adoption of AI, the positioning of multimodal AI with a flexible and secure platform that can handle diverse data and multifaceted analytical functions that can make maximum use of it is becoming more important than ever before. Since its inception, ExaWizards has been consistently engaged in business development, including strategic planning, development, and implementation of services that utilize AI, and has accumulated a wealth of proprietary algorithms as a multi-sector, multi-modal strategy. In addition, since last year, MDV has been fully implementing its open alliance strategy, and has chosen ExaWizards as one of the partners to collaborate with as it seeks to effectively utilize the largest*2 medical practice database in Japan.

ExaWizards, with its strength in multimodal AI technology, and MDV, which has the largest amount of medical data in Japan, will cooperate to promote data-driven businesses that utilize vast amounts of medical data and AI, including digital biomarkers (biological data collected and measured quantitatively using digital terminals) and real world data (data obtained from real clinical practice and real society).

By promoting data-driven businesses that utilize vast amounts of medical data and AI, it will become possible to identify potential markets and provide personalized services that were previously invisible. In addition to the above services, we will also focus on the field of rare diseases, where there is a large development pipeline and further expansion of demand is expected in the future. We will identify and screen potential markets based on medical data and develop patient-centered service programs in the field of rare diseases. Through collaboration between the two companies, we aim to develop innovative medical services and their social implementation, which was not possible in the past.

*1 Multimodal AI: AI that can predict and learn using a variety of data including video, images, voice, and text.
*2 https://en.mdv.co.jp/about-mdv-database/mdv-latest-medical-data-map/

☑︎About ExaWizards
ExaWizards has been developing businesses such as the development and implementation of services leveraging AI as well as strategy planning to consistently address social issues since the establishment in 2016. There are two business segments in the company: AI platform business and AI product business. They accumulate their unique algorithms data through these two segments as a multi-sector multimodal strategy. Their cumulative numbers of patent applications and acquisitions are 191 and 85 (as of the end of December, 2022), respectively. The company also owns advanced technologies in the hardware area such as robots and AI cameras.

☑︎︎About MDV
MDV was founded in August, 2003, and marks its 20th anniversary this year. MDV’s business consists of the following two pillows: the “Data Network Service” that offers hospital management support systems and the “Data-Enabled Service” that utilizes the large-scale healthcare database made up of data collected/accumulated through the Data Network Service to provide pharmaceutical companies and research institutions with analysis data on medicines and diseases. It had a business collaboration agreement with DeNA Co., Ltd. in May, 2022, and combined its database with DeNA’s to create Japan’s largest health insurance database. As for the volume of data available, the hospital database reached 43.22 million patients while the health insurance database 19.11 million as of the end of March, 2023.

[Corporate Profile of ExaWizards]
Company name: ExaWizards Inc.
Location: 21F, Shiodome Sumitomo Bldg., 1-9-2, Higashi Shimbashi, Minato-ku, Tokyo
Establishment: February 2016
Representative: Makoto Haruta, Representative Director & President
Description of business: Industrial innovation and resolution of social issues through the development of AI-enabled services
URL: https://exawizards.com/

<Contact for public relations>
E-mail address of the Public Relations Division of ExaWizards Inc.: publicrelations@exwzd.com